Brief Research Report
Accepted on 27 Jun 2025
Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population
in Pharmacology of Anti-Cancer Drugs